Practical info

I would like to be kept up to date about this programme.


 
 
 


Drive real change in your organisation

A learning experience with real impact on your operations? A management programme tailored to the specific needs of your business? Contact us and discover how we can design and deliver customised programmes for your team that add genuine value to your organisation.

Need help?

Contact our Programme Advisor
Programme Advisor
Tel + 32 9 210 98 84
[email protected]
Find the programme most relevant for you!

Download our programme calendar

Meet Us

Info Sessions & Open Days
21 Apr
Drop In on our Brussels Campus
Category: General Info Sessions

12 May
Drop In on our Ghent Campus
Category: General Info Sessions

09 Jun
Drop In on our Leuven Campus
Category: General Info Sessions

Our approach to learning

It’s all about you and your company’s challenges at Vlerick Business School. Discover our unique approach to learning!

Vlerick expertise in Healthcare Management

  1. Acting with foresight in times of budget austerity

    Horizon scanning is acknowledged to be one of the key components of a demand-driven healthcare system. In this Policy Paper we propose a two-stage structure and organisation of the back-end national part of the horizon scanning process still to be implemented. This will lead to healthcare budgets managed with better foresight, a necessity in the face of breakthrough, some potentially curing therapies coming at a high cost. Taking the Belgian national component of the proposed horizon scanning system to implementation will require a pilot to be carried out. This to test the internal and external validity of the proposed design.
  2. How to address the affordability challenge for advanced therapy medicinal products

    Advanced therapy medicinal products have the potential to offer a durable, life-changing therapeutic effect, possibly with a single administration, for patients who may have few or no alternative treatment options. However, our current Belgian healthcare system is not attuned to these breakthrough therapies, which require short-term substantial payment for potentially lifelong patient value. In collaboration with Inovigate and through dialogue with all stakeholders, Vlerick Business School presents a policy report that contains workable solutions for expensive but curing therapies.
All articles